tiprankstipranks
Advertisement
Advertisement

ARGX Stock Latest News

Argenx price target raised to $1,230 from $1,200 at Morgan Stanley
The FlyArgenx price target raised to $1,230 from $1,200 at Morgan Stanley
5d ago
ARGX
Argenx price target raised to $1,100 from $1,025 at RBC Capital
PremiumThe Fly
Argenx price target raised to $1,100 from $1,025 at RBC Capital
5d ago
ARGX
Argenx price target raised to $1,150 from $1,050 at Wedbush
PremiumThe Fly
Argenx price target raised to $1,150 from $1,050 at Wedbush
5d ago
ARGX
Argenx price target raised to $1,100 from $1,037 at Oppenheimer
PremiumThe Fly
Argenx price target raised to $1,100 from $1,037 at Oppenheimer
5d ago
ARGX
Argenx price target raised to $1,095 from $1,030 at Truist
PremiumThe Fly
Argenx price target raised to $1,095 from $1,030 at Truist
5d ago
ARGX
Argenx price target raised to $1,202 from $940 at H.C. Wainwright
PremiumThe FlyArgenx price target raised to $1,202 from $940 at H.C. Wainwright
5d ago
ARGX
Argenx price target raised to $1,200 from $932 at Citizens
Premium
The Fly
Argenx price target raised to $1,200 from $932 at Citizens
5d ago
ARGX
Argenx price target raised to $1,136 from $1,088 at BofA
Premium
The Fly
Argenx price target raised to $1,136 from $1,088 at BofA
5d ago
ARGX
William Blair says Argenx’s ALKIVIA results boost confidence in Vyvgart DM path
PremiumThe Fly
William Blair says Argenx’s ALKIVIA results boost confidence in Vyvgart DM path
5d ago
ARGX
Argenx rises 16.6%
PremiumThe Fly
Argenx rises 16.6%
5d ago
ARGX
Argenx SE (ARGX) Stock Soars 15% on Positive Phase 3 Study Results
PremiumMarket News
Argenx SE (ARGX) Stock Soars 15% on Positive Phase 3 Study Results
6d ago
ARGX
Argenx rises 14.9%
PremiumThe Fly
Argenx rises 14.9%
6d ago
ARGX
Argenx: Buy Rating Affirmed on Robust Phase III Vyvgart Myositis Data and Multi-Billion Revenue Potential
PremiumRatingsArgenx: Buy Rating Affirmed on Robust Phase III Vyvgart Myositis Data and Multi-Billion Revenue Potential
6d ago
ARGX
Argenx price target raised to $1,215 from $1,075 at Piper Sandler
Premium
The Fly
Argenx price target raised to $1,215 from $1,075 at Piper Sandler
6d ago
ARGX
Zai Lab and Argenx announce results from Alkivia Phase 3 study
Premium
The Fly
Zai Lab and Argenx announce results from Alkivia Phase 3 study
6d ago
ARGX
ZLAB
Argenx announces ALKIVIA study meets primary endpoint
PremiumThe Fly
Argenx announces ALKIVIA study meets primary endpoint
6d ago
ARGX
Argenx Advances Empasiprubart in Rare Nerve Disorder, Adding Long-Term Upside for ARGX Investors
PremiumCompany Announcements
Argenx Advances Empasiprubart in Rare Nerve Disorder, Adding Long-Term Upside for ARGX Investors
9d ago
ARGX
Argenx resumed with a Buy at Guggenheim
PremiumThe Fly
Argenx resumed with a Buy at Guggenheim
18d ago
ARGX
Corning removed from ‘US 1 List’ at BofA
PremiumThe Fly
Corning removed from ‘US 1 List’ at BofA
25d ago
GLW
ARGX
First Tracks Biotherapeutics price target raised to $60 from $30 at Wedbush
PremiumThe FlyFirst Tracks Biotherapeutics price target raised to $60 from $30 at Wedbush
26d ago
ARGX
FBRX
Argenx price target raised to $1,050 from $1,000 at Wedbush
Premium
The Fly
Argenx price target raised to $1,050 from $1,000 at Wedbush
26d ago
ARGX
FBRX
argenx Buy Rating Reaffirmed as FB102 Acquisition and Vyvgart Momentum Support Unchanged $940 Price Target
Premium
Ratings
argenx Buy Rating Reaffirmed as FB102 Acquisition and Vyvgart Momentum Support Unchanged $940 Price Target
26d ago
ARGX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >